Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00698204 · ClinicalTrials.gov registry record · Phase 2
Cox-2 Inhibition in Radiation-induced Oral Mucositis
A Phase 2 study, sponsored by UConn Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
NCT00698204 is a Phase 2 study that has completed, run by UConn Health. The registered enrollment target is 43 participants.
The verdict
NCT00698204, a Phase 2 study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
Study Summary
Oral mucositis refers to ulcerative lesions of the oral mucosa that occur due to radiation therapy given for treatment of head and neck cancer. These lesions are painful, compromise nutrition and quality of life and may necessitate interruptions in radiation therapy, thus adversely affecting cancer therapy outcomes. This study examined the use of an anti-inflammatory medicine to reduce pain and severity of oral mucositis.
Interventions
- DRUG placebo
- DRUG celecoxib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2003-07 |
| Est. Completion | 2013-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00698204
The ClinicalTrials.gov registry entry for NCT00698204 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00698204 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00698204 about?
NCT00698204 is a clinical study titled "Cox-2 Inhibition in Radiation-induced Oral Mucositis". Oral mucositis refers to ulcerative lesions of the oral mucosa that occur due to radiation therapy given for treatment of head and neck cancer. These lesions are painful, compromise nutrition and quality of life and may necessitate interruptions in radiation therapy, thus adversely affecting cancer ...
What is the current status of trial NCT00698204?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2003-07. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00698204?
The interventions under investigation include: placebo (DRUG), celecoxib (DRUG).
Who is sponsoring clinical trial NCT00698204?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.